Literature DB >> 1658044

Deficiency in phosphorylase phosphatase activity despite elevated protein phosphatase type-1 catalytic subunit in skeletal muscle from insulin-resistant subjects.

B L Nyomba1, D L Brautigan, K K Schlender, W Wang, C Bogardus, D M Mott.   

Abstract

Glycogen synthase is activated by protein phosphatase type-1 (PP-1). The spontaneous PP-1 activity accounts for only a small fraction of total PP-1 activity, which can be exposed by trypsin digestion of inhibitor proteins in the presence of Mn2+. We determined total PP-1 activity in muscle biopsies from insulin-sensitive and -resistant nondiabetic Pima Indians. Inhibitor-2 sensitive PP-1 represented 90% of total phosphatase activity. Spontaneous and total PP-1 activities were reduced in insulin resistant subjects (P less than 0.05-0.01), suggesting that the reduced PP-1 activity is not the result of inhibition by trypsin-labile phosphatase regulatory subunits. This difference was further investigated by Western blots using two different antibodies. An antibody raised against the rabbit muscle PP-1 catalytic subunit was used to analyze muscle extracts concentrated by DEAE-Sepharose adsorption. An antibody raised against a peptide derived from the COOH-terminal end of the PP-1 catalytic subunit was used to analyze crude muscle extracts. Both antibodies recognized a PP-1 catalytic subunit of approximately 33 kD, which unexpectedly was more abundant in insulin-resistant subjects (P less than 0.05-0.01). The increase in the tissue PP-1 protein content may be a response to compensate for the impairment in the enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658044      PMCID: PMC295665          DOI: 10.1172/JCI115464

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

2.  The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle.

Authors:  P Dent; A Lavoinne; S Nakielny; F B Caudwell; P Watt; P Cohen
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

3.  Acute inhibition of insulin-stimulated glucose transport by the phosphatase inhibitor, okadaic acid.

Authors:  S Corvera; S Jaspers; M Pasceri
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

4.  The regulation of glycogen metabolism. Purification and characterisation of protein phosphatase inhibitor-1 from rabbit skeletal muscle.

Authors:  G A Nimmo; P Cohen
Journal:  Eur J Biochem       Date:  1978-06-15

5.  Reversible inhibition of cyclic AMP-dependent protein kinase by insulin.

Authors:  R J Walkenbach; R Hazen; J Larner
Journal:  Mol Cell Biochem       Date:  1978-02-24       Impact factor: 3.396

6.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

7.  Correlation between muscle glycogen synthase activity and in vivo insulin action in man.

Authors:  C Bogardus; S Lillioja; K Stone; D Mott
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle.

Authors:  J F Tanti; T Grémeaux; E Van Obberghen; Y Le Marchand-Brustel
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

9.  Phosphorylase phosphatase complex from skeletal muscle. Activation of one of two catalytic subunits by manganese ions.

Authors:  D L Brautigan; C Picton; E H Fischer
Journal:  Biochemistry       Date:  1980-12-09       Impact factor: 3.162

10.  Comparison of the substrate specificities of protein phosphatases involved in the regulation of glycogen metabolism in rabbit skeletal muscle.

Authors:  J F Antoniw; H G Nimmo; S J Yeaman; P Cohen
Journal:  Biochem J       Date:  1977-02-15       Impact factor: 3.857

View more
  5 in total

Review 1.  Protein phosphatase-1 and insulin action.

Authors:  L Ragolia; N Begum
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

2.  Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.

Authors:  B Andersen; A Rassov; N Westergaard; K Lundgren
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

3.  Defective insulin response of phosphorylase phosphatase in insulin-resistant humans.

Authors:  Y Kida; I Raz; R Maeda; B L Nyomba; K Stone; C Bogardus; J Sommercorn; D M Mott
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

4.  Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives.

Authors:  C Schalin-Jäntti; H Yki-Järvinen; L Koranyi; R Bourey; J Lindström; P Nikula-Ijäs; A Franssila-Kallunki; L C Groop
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

5.  Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes.

Authors:  M Board; M Bollen; W Stalmans; Y Kim; G W Fleet; L N Johnson
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.